Ipramid Respirator Solution 250 mcg/ml contains Ipratropium Bromide, an anticholinergic bronchodilator formulated for inhalation via nebulizer. It is used in the management of chronic obstructive pulmonary disease (COPD) and as adjunctive therapy in bronchial asthma. The respirator (nebulizer) solution is especially suitable for patients who have difficulty using inhalers, including young children, elderly patients, and those experiencing severe airway obstruction. By delivering medication directly to the lungs, Ipramid Respirator Solution provides effective bronchodilation with minimal systemic exposure.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Anticholinergic Bronchodilators
Respiratory Agents

Composition

Each ml of solution contains Ipratropium Bromide 250 mcg.

Indications

Ipramid Respirator Solution 250 mcg/ml is indicated for:

• Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema

• Adjunctive therapy in bronchial asthma

• Relief of reversible bronchospasm in patients with obstructive airway diseases

It may be used alone or in combination with other bronchodilators as prescribed by a healthcare professional.

Pharmacology

Ipratropium Bromide is a quaternary ammonium anticholinergic agent that blocks muscarinic receptors in the bronchial smooth muscle. This action inhibits the effects of acetylcholine, preventing reflex bronchoconstriction and resulting in bronchodilation. Ipratropium acts locally in the respiratory tract and is minimally absorbed into the systemic circulation, which reduces the risk of systemic anticholinergic side effects. The onset of bronchodilation occurs within minutes after nebulization and lasts for several hours.

Dosage and Administration

The dosage of Ipramid Respirator Solution should be individualized according to the patient’s age, clinical condition, and response to therapy.

• Administered by inhalation using a suitable nebulizer

• The prescribed dose may be used alone or diluted with normal saline as directed

• Use only under medical supervision, especially in children

Proper nebulization technique should be followed to ensure optimal drug delivery.

Contraindications

Ipramid Respirator Solution 250 mcg/ml is contraindicated in patients with:

• Known hypersensitivity to ipratropium bromide, atropine, or its derivatives

• Known allergy to any component of the formulation

Precautions and Warnings

• Use with caution in patients with narrow-angle glaucoma, prostatic hyperplasia, or urinary retention

• Avoid contact of the nebulized solution with the eyes to prevent ocular side effects

• Not intended as a sole therapy for acute severe asthma attacks unless advised by a physician

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Adverse Effects

Ipramid Respirator Solution is generally well tolerated. Possible adverse effects include:

• Dry mouth

• Throat irritation

• Cough

• Headache

• Rarely, paradoxical bronchospasm or allergic reactions

Most adverse effects are mild and transient.

Drug Interactions

Ipramid may be used together with beta-agonist bronchodilators and inhaled corticosteroids. Caution is advised when used with other anticholinergic drugs due to potential additive effects.

Storage

Store in a cool and dry place, protected from light. Do not freeze. Keep out of reach of children.

Conclusion

Ipramid Respirator Solution 250 mcg/ml is an effective and well-tolerated nebulized anticholinergic bronchodilator for the management of COPD and other obstructive airway conditions. Its suitability for nebulization makes it an important treatment option for patients who require assisted inhalation therapy.